OptimizeRx Corp — Net Income by Fiscal Year
15 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/c63cc9ec-dcd8-4c35-8953-c9bb8be5ac7c/serie/net-income
| Fiscal year | Net Income | Period | Evidence |
|---|---|---|---|
| FY 2025 | $5.1M | 2025-01-01 – 2025-12-31 | evidence 0001448431-26-000005 |
| FY 2024 | $-20.1M | 2024-01-01 – 2024-12-31 | evidence 0001213900-25-025576 |
| FY 2023 | $-17.6M | 2023-01-01 – 2023-12-31 | evidence 0001213900-25-025576 |
| FY 2022 | $-11.4M | 2022-01-01 – 2022-12-31 | evidence 0001213900-23-019233 |
| FY 2021 | $378.1k | 2021-01-01 – 2021-12-31 | evidence 0001213900-22-009736 |
| FY 2020 | $-2.2M | 2020-01-01 – 2020-12-31 | evidence 0001213900-21-013996 |
| FY 2019 | $-3.1M | 2019-01-01 – 2019-12-31 | evidence 0001213900-20-007491 |
| FY 2018 | $226.3k | 2018-01-01 – 2018-12-31 | evidence 0001213900-19-003962 |
| FY 2017 | $-2.1M | 2017-01-01 – 2017-12-31 | evidence 0001213900-18-002722 |
| FY 2016 | $-1.5M | 2016-01-01 – 2016-12-31 | evidence 0001213900-17-002093 |
| FY 2015 | $-595.1k | 2015-01-01 – 2015-12-31 | evidence 0001213900-16-011609 |
| FY 2014 | $-1.0M | 2014-01-01 – 2014-12-31 | evidence 0001213900-15-002228 |
| FY 2013 | $-267.3k | 2013-01-01 – 2013-12-31 | evidence 0001213900-15-002228 |
| FY 2012 | $-454.6k | 2012-01-01 – 2012-12-31 | evidence 0001255294-14-000254 |
| FY 2011 | $-2.1M | 2011-01-01 – 2011-12-31 | evidence 0001255294-13-000182 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).